GENTIAN MARKING PAD * 581057

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2003-09-11 for GENTIAN MARKING PAD * 581057 manufactured by Bd Ophthalmic Systems.

Event Text Entries

[317707] The account thinks the marking pads cuased dlk in 7 cases in 8/2003.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1211998-2003-00003
MDR Report Key494627
Report Source05
Date Received2003-09-11
Date Mfgr Received2003-08-13
Device Manufacturer Date2003-06-01
Date Added to Maude2003-11-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactPAT FILOSA
Manufacturer Street411 WAVERLEY OAKS ROAD BLDG. 2, SUITE 229
Manufacturer CityWALTHAM MA 02452
Manufacturer CountryUS
Manufacturer Postal02452
Manufacturer Phone*
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGENTIAN MARKING PAD
Generic NameBD VISIMARK VIOLET MARKING PAD
Product CodeHMQ
Date Received2003-09-11
Returned To Mfg2003-08-21
Model Number*
Catalog Number581057
Lot Number3155268
ID Number*
Device Expiration Date2008-06-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key483339
ManufacturerBD OPHTHALMIC SYSTEMS
Manufacturer Address411 WAVERLEY OAKS ROAD BLDG. 2, SUITE 229 WALTHAM MA 02452 US
Baseline Brand NameBD VISIMARK GENTIAN VIOLET MARKING PAD
Baseline Generic NameMD VISIMARK GENTIAN MARKING PAD
Baseline Model NoNA
Baseline Catalog No581057
Baseline IDNA
Baseline Device FamilyBD VISITEC PRE-INKED MARKING PADS
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK884718
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2003-09-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.